Topped up in the low 50s for a long term hold.
$8 billion market and no serious competition.
This may dip further in the short term but strong news expected in Q3 and Q4.
Ann: First Patient Treatment in the U.S. in the VISABL-AFL Trial, page-2
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.010(1.69%) |
Mkt cap ! $159.4M | |||
| Open | High | Low | Value | Volume |
| 58.0¢ | 60.0¢ | 57.0¢ | $67.60K | 115.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 850 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 109570 | 4 |
View Market Depth
| Last trade - 14.50pm 15/10/2024 (20 minute delay) ? |
| IMR (ASX) Chart |